Cargando…
Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study
BACKGROUND: Syndecan-1 is a heparan sulfate proteoglycan expressed on plasma cells, especially myeloma cells, and can exist in serum as soluble syndecan-1 after shedding from the cell surface. Soluble syndecan-1 has been suggested to promote myeloma cell growth and to be an independent prognostic fa...
Autores principales: | Kim, Ji Myung, Lee, Jung Ae, Cho, In Sung, Ihm, Chun Hwa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983025/ https://www.ncbi.nlm.nih.gov/pubmed/21120190 http://dx.doi.org/10.5045/kjh.2010.45.2.115 |
Ejemplares similares
-
Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma?
por: Lee, Je-Jung
Publicado: (2010) -
Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
por: Lamorte, S, et al.
Publicado: (2012) -
Low Soluble Syndecan-1 Precedes Preeclampsia
por: Gandley, Robin E., et al.
Publicado: (2016) -
Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution Experience
por: Jung, Hyun Ae, et al.
Publicado: (2018) -
Soluble syndecan-1 and glycosaminoglycans in preeclamptic and normotensive pregnancies
por: Hassani Lahsinoui, H., et al.
Publicado: (2021)